The Climate Change and Health Gateway (CCHG) for Enhancing Biomedical, Health, an

气候变化与健康网关 (CCHG) 旨在加强生物医学、健康和

基本信息

  • 批准号:
    8389398
  • 负责人:
  • 金额:
    $ 14.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-01 至 2013-02-01
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Climate Risk Analysis Division of Lumenetec, LLC, proposes to develop the Climate Change and Health Gateway (CCHG), an innovative and ground-breaking software tool that will radically enhance biomedical, health and climate-change informatics. CCHG will empower decision-makers in both the public and private sectors by providing critical, quantitative information of the health impacts of climate change in a GIS-based platform. The proposed technology will enable non-technical decision makers to systematically leverage the outputs of high-end Global Climate Model (GCM) simulations for understanding, predicting and responding to the health impacts of climate change. CCHG will support the National Library of Medicine's mission of enabling biomedical research, supporting health care and public health, and promoting healthy behavior by significantly enhancing its information services relevant to environmental health, health services research, and public health. Therefore, decision-makers from individual citizens to regional and national governments will be able to confidently formulate mitigation and adaption strategies in order to reduce the adverse effects of climate change on human health. Lumenetec's proposed CCHG technology will benefit the public as a whole by increasing awareness of the adverse effects of climate change on human health. In the Phase I, Lumenetec proposes to work with a team of experts from academia, industry, and regional governments to: 1) conduct a needs analysis; 2) design and build a CCHG prototype; 3) demonstrate the feasibility of CCHG using real data; and, 4) plan for the Phase II program. In the Phase II, Lumenetec will build on the Phase I prototype to further develop CCHG, resulting in a stable, user-friendly, commercial product. In addition, Lumenetec will launch a client pilot program in the Phase II and will aggressively commercialize CCHG among the numerous climate change stakeholders identified in the Phase I. This program will result in a complete, turnkey solution that will enable the various stakeholders of the health impact assessment community to leverage the outputs of current and future long-term simulations of Global Climate Models for the quantitative assessment of the health effects of climate change. PUBLIC HEALTH RELEVANCE: Lumenetec's Climate Change and Health Gateway (CCHG) will radically enhance the integration of climate change, biomedical, and health information, thereby providing a more complete picture of the relationships between climate and disease for specific populations, locations, or health conditions. In addition, CCHG will permit users to merge data from many sources and to mine the data for discovering, visualizing, and testing hypotheses about the climate effects on particular diseases or population groups. As a result, CCHG will benefit the public as a whole by providing decision makers from individual citizens to regional and national governments with critical information for understanding, predicting and responding to the adverse health impacts of climate change.
描述(由申请人提供):Lumenetec, LLC 的气候风险分析部门提议开发气候变化与健康网关 (CCHG),这是一种创新且突破性的软件工具,将从根本上增强生物医学、健康和气候变化信息学。 CCHG 将通过在基于 GIS 的平台上提供气候变化对健康影响的关键定量信息,为公共和私营部门的决策者提供支持。拟议的技术将使非技术决策者能够系统地利用高端全球气候模型(GCM)模拟的输出来理解、预测和应对气候变化对健康的影响。 CCHG 将通过显着增强与环境健康、卫生服务研究和公共卫生相关的信息服务来支持国家医学图书馆的使命,即促进生物医学研究、支持医疗保健和公共卫生以及促进健康行为。因此,从公民个人到地区和国家政府的决策者将能够自信地制定缓解和适应战略,以减少气候变化对人类健康的不利影响。 Lumenetec 提出的 CCHG 技术将提高人们对气候变化对人类健康不利影响的认识,从而使整个公众受益。在第一阶段,Lumenetec 建议与来自学术界、工业界和地方政府的专家团队合作:1)进行需求分析; 2)设计并构建CCHG原型; 3)利用真实数据论证CCHG的可行性; 4) 第二阶段计划的规划。在第二阶段,Lumenetec 将在第一阶段原型的基础上进一步开发 CCHG,从而开发出稳定、用户友好的商业产品。此外,Lumenetec 将在第二阶段启动客户试点计划,并将在第一阶段确定的众多气候变化利益相关者中积极将 CCHG 商业化。该计划将产生一个完整的统包解决方案,使健康影响评估界的各个利益相关者能够利用全球气候模型当前和未来长期模拟的输出来定量评估气候变化对健康的影响。 公共健康相关性: Lumenetec 的气候变化与健康网关 (CCHG) 将从根本上增强气候变化、生物医学和健康信息的整合,从而更全面地了解特定人群、地点或健康状况的气候与疾病之间的关系。此外,CCHG 将允许用户合并来自多个来源的数据并挖掘数据,以发现、可视化和测试有关气候对特定疾病或人群影响的假设。因此,CCHG 将为从公民个人到地区和国家政府的决策者提供了解、预测和应对气候变化对健康的不利影响的关键信息,从而使整个公众受益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Bock其他文献

Robert Bock的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 14.09万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 14.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 14.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 14.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 14.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 14.09万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 14.09万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 14.09万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 14.09万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 14.09万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了